Ignite Creation Date:
2025-12-24 @ 3:14 PM
Ignite Modification Date:
2025-12-31 @ 2:44 AM
Study NCT ID:
NCT05169892
Status:
RECRUITING
Last Update Posted:
2021-12-27
First Post:
2021-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Aquablation in Benign Prostatic Hyperplasia in Canada
Sponsor:
Can-Am HIFU Inc.
Organization:
Study Overview
Official Title:
Canadian Cohort of Aquablation, a Robotically Executed, Surgeon-guided, High-pressure Water Jet Ablation Therapy for Endoscopic Resection of Prostate Tissue, in Benign Prostatic Hyperplasia (BPH).
Status:
RECRUITING
Status Verified Date:
2021-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To document the clinical outcome of Aquablation therapy for BPH patient in Canadian cohort.
Detailed Description:
Patients will be followed up for 3 years as standard of care.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: